[Verse 1]
Alpha-2 agonists, clonidine on deck
Dexmedetomidine keeping ICU in check
Hit the presynaptic receptor, drop the NE release
Sympatholytic properties bringing pain some peace
Clonidine patch for chronic, epidural for the block
Dex for procedural sedation, round the clock
Hypotension, bradycardia, watch the vital signs
Mechanism: descending modulation through the spinal lines
[Chorus]
Twelve other agents, heterogeneous crew
Bone pain, head pain, visceral — each one got a queue
Alpha-2 for sympathetic, bisphosphonate for bone
Triptans hunting serotonin, antispasmodics for the groan
Nav one-point-eight blockers knocking at the gate
Novel non-opioid targets — pharmacology's fate
[Verse 2]
Bisphosphonates inhibit osteoclast resorption
Denosumab blocks RANK-L — receptor interception
Zoledronic acid quarterly for metastatic bone
Calcitonin drops the calcium, works the nasal zone
Inhibits osteoclasts through calcitonin receptors sited
Plus central analgesic effects — still somewhat debated
Salmon calcitonin, vertebral fractures in the game
Short-term relief, but long-term benefit? Murky, never plain
[Chorus]
Twelve other agents, heterogeneous crew
Bone pain, head pain, visceral — each one got a queue
Alpha-2 for sympathetic, bisphosphonate for bone
Triptans hunting serotonin, antispasmodics for the groan
Nav one-point-eight blockers knocking at the gate
Novel non-opioid targets — pharmacology's fate
[Verse 3]
Migraine specific — triptans serotonin one-B one-D
Vasoconstrict the meningeal vessels, abort the misery
CGRP antagonists — gepants block the peptide cold
Lasmiditan hits the one-F receptor, no vasoconstriction told
Erenumab, fremanezumab — monoclonal prevention lane
Anti-CGRP antibodies quarterly, reducing migraine rain
Hyoscine blocks muscarinic, smooth muscle cramp released
Dicyclomine for IBS, visceral spasm decreased
[Bridge]
Now we push the frontier, suzetrigine in the ring
Nav one-point-eight selective — peripheral pain a stinging thing
Spares the cardiac channels, targets sensory alone
Tanezumab chased NGF but joint destruction — thrown a bone
Anti-NGF antibodies shelved by safety red flags raised
Accelerated osteoarthritis — enthusiasm hazed
But the target still legitimate, the science still stands clear
Non-opioid chronic pain solutions — engineered
[Chorus]
Twelve other agents, heterogeneous crew
Bone pain, head pain, visceral — each one got a queue
Alpha-2 for sympathetic, bisphosphonate for bone
Triptans hunting serotonin, antispasmodics for the groan
Nav one-point-eight blockers knocking at the gate
Novel non-opioid targets — pharmacology's fate
[Outro]
Clonidine, dex, bisphosphonates, calcitonin — locked in
Triptans, gepants, antispasmodics — stack 'em up, begin
Suzetrigine selective sodium, next generation real
Twelve agents deep in the arsenal — precision pain reveal